PSC
BDSI

Piper Sandler & Co’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Piper Sandler & Co’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-48,000
Closed -$504K – 153
2015
Q1 		$504K Buy
+48,000
New +$656K 0.21% 44

Other funds holding BDSI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's BDSI Position: Q2 2015 in Review

Piper Sandler & Co sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2015, closing a stake of 48,000 shares — an estimated $504K sold.

Piper Sandler & Co first reported a position in BDSI in Q1 2015 and held it in 1 quarter. The position peaked at $504K in Q1 2015. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2015.

  • Piper Sandler & Co reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 48,000 BioDelivery Sciences International, Inc. shares in Q2 2015, an estimated $504K.
  • Piper Sandler & Co first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 1 quarter.
  • Piper Sandler & Co's BioDelivery Sciences International, Inc. position peaked at $504K in Q1 2015.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2015.

Based on Piper Sandler & Co's 13F filing for Q2 2015, filed 14 Aug 2015.